Bevacizumab in the treatment of non-small cell lung cancer with brain metastases
10.3760/cma.j.issn.1673-422X.2017.11.015
- VernacularTitle:贝伐珠单抗治疗非小细胞肺癌脑转移
- Author:
Mengshi LIU
1
;
Haiyan YANG
;
Hongmei LI
Author Information
1. 266000,青岛大学附属医院肿瘤科
- Keywords:
Carcinoma,non-small-cell lung;
Neoplasm metastases;
Bevacizumab
- From:
Journal of International Oncology
2017;44(11):864-865
- CountryChina
- Language:Chinese
-
Abstract:
The occurrence of brain metastases in lung cancer affects the prognosis of patients.Following surgery,whole brain radiotherapy,stereotactic radiotherapy and chemotherapy,anti-angiogenesis therapy has become a new treatment option for lung cancer patients with brain metastases.As an anti-angiogenic drug,bevacizumab has a better effect of controlling peritumoral edema.Studies have shown that bevacizumab combined with chemotherapy,radiotherapy to treat non-small cell lung cancer with brain metastasis has a good efficacy and safety.
